| circRNAs | Samples | Clinical association | Diagnostic value | Sample size | Ref | Sens | Spec | AUC | Cutoff value | Case | Control |
| Oncogenic | | | | | | | | | | hsa_circ_0066444 | Tissues | Lymphatic metastasis | 0.7075 | 0.6887 | 0.7328 | — | 106 | 106 | [71] | hsa_circRNA_102958 | Tissues | TNM stage | 0.61 | 0.86 | 0.74 | — | 30 | 30 | [72] | hsa_circ-0000467 | Tissues | TNM stage | 0.705 | 0.648 | 0.790 | — | 51 | 51 | [66] | Antioncogenic | | | | | | | | | | hsa_circ_0067582 | Tissues | Tissue CEA level and stages | 0.552 | 0.750 | 0.671 | 10.61 | 96 | 96 | [83] | hsa_circ_0005758 | | CEA level and perineural invasion | 0.750 | 0.677 | 0.721 | 10.20 | | | | hsa_circ_0003159 | Tissues | Gender, distal metastasis, and TNM stage | 0.852 | 0.565 | 0.75 | 12.31 | 108 | 108 | [82] | hsa_circ_0005654 | Tissues | — | — | — | 0.927 | — | 68 | 68 | [79] | hsa_circ_00001649 | Tissue | Pathological differentiation | 0.711 | 0.816 | 0.834 | 0.2269225 | 76 | 76 | [80] | hsa_circ_0000096 | Tissues | Gender, invasion, and TNM stage | 0.88 | 0.56 | 0.82 | 12.9 | 101 | 101 | [65] | hsa_circ_0014717 | Tissues | Tumor stage, distal metastasis, tissue CEA, and CA19-9 expression | 0.5938 | 0.8125 | 0.696 | 12.14 | 96 GC | 96 | [11] | hsa_circ_0001895 | Tissues | Tumor differentiation, Borrmann type, and tissue CEA expression | 0.678 | 0.857 | 0.792 | 9.53 | 96 GC | 96 | [81] | hsa_circ_002059 | Tissues | Distal metastasis, TNM stage, gender, and age | 0.81 | 0.62 | 0.73 | 12.9 | 101 | 101 | [84] | hsa_circ_0006633 | Tissues | Distal metastasis and tissue CEA level | 0.60 | 0.81 | 0.741 | 8.17 | 96 | 96 | [85] | hsa_circ_0130810 | Tissues | TNM stage and lymphatic metastasis | 0.7742 | 0.6800 | 0.7481 | 1.443 | 28 | 28 | [86] | hsa_circ_0006848 | Plasma | Tumor differentiation and tumor size | — | — | 0.733 | — | 30 | 30 | [77] | hsa_circ_0000745 | Plasma | TNM stage | 0.855 | 0.45 | 0.683 | | 60 | 60 | [78] | hsa_circ_0000190 | Tissues, | Tumor diameter, lymphatic and distal metastasis, TNM stage, and CA19-9 | 0.721 | 0.683 | 0.75 | 6.83 | 104 | 104 | [67] | Plasma | CEA | 0.414 | 0.875 | 0.60 | 3.07 | 104 | 104 | | hsa_circ_0000181 | Tissues, plasma | Tumor size, lymphatic metastasis, distal metastasis, and CA19-9 | 0.990 | 0.852 | 0.756 | 9.40 | 115 | 115 | [73] | | Tumor differentiation and CEA level | 99.0% | 20.6% | 0.582 | 7.27 | 102 | 105 | | hsa_circ_0000520 | Tissues, | TNM stage | 0.5357 | 0.8571 | 0.6129 | — | 56 | 56 | [74] | Plasma | CEA expression | 0.8235 | 0.8444 | 0.8967 | — | 45 | 17 | | hsa_circ_0001821 | Tissues, | Tumor depth and lymph node metastasis | — | — | 0.792 | — | 80 | 80 | [68] | Plasma | — | — | — | 0.872 | — | 30 | 30 | | hsa_circ_0001017 | Tissues, | Age, tumor size, invasion, TNM stages, distal metastasis, and CEA levels | 0.794 | 0.811 | 0.871 | — | 121 | 121 | [75] | Plasma | Gender, tumor size, differentiation, and distal metastasis | 0.676 | 0.897 | 0.851 | — | | | | hsa_circ_0061276 | Tissues, | Age, tumor size, TNM stages, distal metastasis, and CEA levels | 0.913 | 0.507 | 0.764 | — | | | | Plasma | Gender, tumor size, differentiation, and CEA levels | 0.758 | 0.959 | 0.849 | — | | | | hsa_circ_0000419 | Tissues, | Borrmann type and differentiation grade | 0.552 | 0.677 | 0.642 | 8.14 | 96 | 96 | [76] | Plasma | Tumor stage, lymphatic and distal metastasis, venous and perineural invasion | 0.682 | 0.884 | 0.840 | 4.9 | 44 | 43 | |
|
|